International Outcomes of COVID-19 during Pregnancy and a Literature Review on Maternal and Neonatal Outcomes

Umer, Sarwat; Reindorf, Maxine; Zill‐E‐Huma, Rabia; Wilkinson, Alexander

doi:10.4236/ojog.2021.114043

Cited by 1 publication

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As our knowledge of the disease and treatment modalities has evolved, we became aware that pregnant women are not more susceptible to acquiring the infection compared to non-pregnant population, but may be at higher risk of developing severe symptoms especially in the third trimester because of the physiological changes, relative immune-compromised state of pregnancy, and risk of consequent iatrogenic preterm deliveries [2]. Women with high BMI, multiple pregnancies, co-morbidities like hypertension, diabetes, cardiac or chronic kidney disease and those from Black, Asian and minority ethnic groups may be more susceptible to severe disease [3].…”

Section: Introductionmentioning

confidence: 99%

Treatment Strategies for COVID-19 in Pregnancy: Short Review of Current Recommendations

Zill‐E‐Huma¹,

Wilkinson²

2021

OJOG

Self Cite

View full text Add to dashboard Cite

Since the emergence of COVID-19 in Dec. 2019, our knowledge of disease and treatment modalities has evolved significantly. Pregnancy poses a unique challenge in the context of the management of infectious diseases because of the effect of the disease and treatment modalities on the mother and fetus. There has been a lack of active inclusion of pregnant women in various trials including vaccination trials in COVID-19; hence most information on treatment strategies became available from adult non-pregnant population. This article outlines the short review on current management strategies available to the adult pregnant population with COVID-19 in light of available evidence until 30 th April 2021.

show abstract

Section: Introductionmentioning

confidence: 99%